U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from U11248. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In U11248 Today - Breaking & Trending Today

ILD Not Increased With MTX in Patients With Dermatomyositis

Treatment with methotrexate was not associated with an increased risk for interstitial lung disease (ILD) in patients with dermatomyositis. ....

New York , United States , Jillt Shah , York University Langone Health , National Institutes , Health Sponsored All , New York University Langone Health , New York City , Biologic Therapy , Interstitial Lung Disease , Alignant Neoplasia , Alignant Neoplasm , Antineoplastic Drug , Nti Cancer Agents , Monoclonal Antibody , Electronic Health Records ,

Combo Therapy Prolongs Survival in Gastric Cancer Patients

The overall survival advantage held regardless of PD-L1 status in patients receiving the first-line combination of cadonilimab and standard chemotherapy. ....

United States , Jiafu Ji , American Association For Cancer Research , Drug Administration , Institute For Cancer Research , University Cancer Hospital , American Association , Cancer Research , Peking University Cancer Hospital , Beijing Institute , New Treatment Paradigm , Advanced Gastric , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Combination Chemotherapy , Gastric Cancer , Alignant Stomach Neoplasm , Stomach Cancer , Gastric Carcinoma , Alignant Neoplasia , Alignant Neoplasm , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents ,

FDA Expands Enhertu Indication to HER2-Positive Solid Tumors

The move from the FDA marks the first tumor-agnostic approval of a HER2-directed therapy and antibody drug conjugate. ....

United States , University Of Texas Md Anderson Cancer Center , Drug Administration , Daiichi Sankyo Inc , Daiichi Sankyo , Cancer Center , Boxed Warning , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Nt Specialty , Ead And Neck Surgery Ent Speciality ,

Continued Benefit, More Toxicity With Osimertinib-Chemo

Patients with advanced EGFR-mutated NSCLC who were given osimertinib plus chemotherapy up front continue to show improved outcomes after initial progression, suggests ongoing trial data. ....

Noord Holland , Natalia Isabel Valdiviezo Lama , Netherlands Cancer Institute , Drug Administration , National Institute Of Neoplastic Diseases , European Lung Cancer Congress , National Institute , Neoplastic Diseases , Medscape Medical News , Joop De Langen , Non Small Cell Lung Cancer , Lung Cancer , Ung Carcinoma , Ancer Of The Lung , Biologic Therapy , Tyrosine Kinase Inhibitor , Small Cell Lung Cancer , Small Cell Lung Cancer , At Cell Lung Cancer , Etastatic Carcinoma , Metastatic Cancer ,

First-Line Highly Effective Therapy Better for Pediatric MS

New research supports the use of highly effective therapies as first-line treatment in children with relapsing-remitting pediatric-onset multiple sclerosis. ....

Department Of Pediatric Neurology , University Angers , Expanded Disability Status Scale , Nail Benallegue , Pediatric Neurology , Multiple Sclerosis Ms , S Multiple Sclerosis , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents , Glatiramer Acetate , Interferon Beta , Fn Beta , Interferon Beta , Monoclonal Antibody ,